DEVELOPMENT & VALIDATION OF HPLC METHOD FOR ANALYSIS OF SOME ANTIHYPERTENSIVE AGENTS IN THEIR PHARMACEUTICAL DOSAGE FORMS
A simple, fast, specific and accurate reverse-phase high performance liquid chromatography (RP-HPLC) method has been developed and subsequently validated for simultaneous estimation of Aliskiren (ALN) and Felodipine (FLD) from their dosage forms. Agilent 1200 infinity LC equipped with UV-Visible with EZChrom Elite compact version 3.3.2 SP2 software was used. Chromatographic separation was achieved isocratically on a Hypersil BDS C8 column (150Ã—4.6 mm, 5 Î¼ particle size) using a mobile phase, Water (adjusted to pH 3.0 with 10%v/v ortho-phosphoric acid) , Acetonitrile and Methanol in the ratio ofÂ 20:30:50 v/v/v and UV detection was carried out at 254 nm for both the drugs ALN and FLD. The retention time for ALS and FLD was found to be 4.26 and 2.96 min respectively, and recoveries were found between 98 and 102%.Â The method was found linear over the range of 150-450 Âµg mL-1 for ALS andÂ 5-15 Âµg mL-1 for FLD. The method has been successfully applied to assess the assay of solid dosage formulations.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).